期刊文献+

3-烟酰胺基-1,2,4-苯并三嗪-1,4-二氮氧化物的合成及体外抗肿瘤活性的测定 被引量:2

Synthesis of 3-Nicotinamide-1,2,4-Benzotriazine-1,4-Dioxide and the Determination of Its Anti-Tumor Activity in Vitro
原文传递
导出
摘要 目的合成3-烟酰胺基-1,2,4-苯并三嗪-1,4-二氮氧化物;测定3-烟酰胺基-1,2,4-苯并三嗪-1,4-二氮氧化物体外抗肿瘤活性。方法以苯并呋咱氮氧化物(BFO)和氨基氰为起始原料合成中间体3-氨基-1,2,4-苯并三嗪-1,4-二氮氧化物,所得的中间体和烟酰氯反应得目标化合物。以人乳腺癌MCF-7细胞、人肝癌HepG2细胞为模型,采用MTT分析法,测定3-烟酰胺基-1,2,4-苯并三嗪-1,4-二氮氧化物体外抗肿瘤活性。结果所合成的目标化合物经氢谱(1H-NMR)、质谱(MS)和红外光谱(IR)确证,纯度经HPLC检测达99.24%。结论合成了3-烟酰胺基-1,2,4-苯并三嗪-1,4-二氮氧化物;3-烟酰胺基-1,2,4-苯并三嗪-1,4-二氮氧化物对人乳腺癌MCF-7细胞、人肝癌HepG2细胞的活性大于替拉扎明。 OBJECTIVE To synthesize 3-nicotinamide-1,2,4-benzotriazine-1,4-dioxide and to determine its anti-tumor activity in vitro.METHODS Cyanogenamide and benzofuroxan were used as starting materials to prepare the intermediate(3-amino-1,2,4-benzotriazine-1,4-dioxide,Tirapazamine).The objective substance was obtained from the reaction of the intermediate and nicotinic acyl chloride.The in vitro antitumor activities of the synthesized compounds were determined by MTT method using MCF-7 and HepG2 cells.RESULTS The obtained compounds were identified by 1H-NMR,MS and IR.The purity of the objective substance determined by HPLC was 99.24%.CONCLUSION The anti-tumor activity of 3-nicotinamide-1,2,4-benzotriazine-1,4-dioxide is much better than tirapazamine.
出处 《中国药学杂志》 CAS CSCD 北大核心 2012年第8期639-641,共3页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(81072613) 国家科技重大专项"重大新药创新"(2009ZX09103-016)
关键词 替拉扎明 3-烟酰胺基-1 2 4-苯并三嗪-1 4-二氮氧化物 抗肿瘤活性 tirapazamine 3-nicotinamide-1 2 4-benzotriazine-1 4-dioxide anti-tumor activity
  • 相关文献

参考文献7

  • 1BROWN J M.Tumor hypoxia in cancer therapy[J].Methods Enz-ymol,2007,435(12):297-321.
  • 2SU Z,WU J B.The progress of tumor hypoxia-radiosensitizer[J].J Military Surgeon Southwest China(西南军医),2010,12(3):528-531.
  • 3YAN Y Q,SUN W J,ZHOU P K.The mechanism of radiosensiti-zer and the progress of clinical research[J].Chin J Radiol MedProt(中华放射医学与防护杂志),2004,24(3):292-294.
  • 4REDDY S B,WILLIAMSON S K.Tirapazamine:a novel agenttargeting hypoxic tumor cells[J].Expert Opin Investig Drugs,2009,18:77-87.
  • 5GU F,LIU X Q.The molecular mechanism of tumor radiosensiti-zer[J].Int J Radiat Med Nucl Med,2006,30(5):298-301.
  • 6MICHAEL R H,DIETMAR W S,DAVID J C,et al.Nicotiamideas a radiosensitizer in tumors and normal tissues:the importance ofdrug dose and timing[J].Radiother Oncol,1997,45:167-174.
  • 7LUO S Y,HUANG H M,XUE Z,et al.The progress of synthesisof tirapazamine and its derivatives[J].Jiangxi Med J(江西医药),2008,43(4):369-371.

同被引文献9

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部